T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICON
1276
DELISTED
Iconix Brand Group, Inc.
ICON
| $11.7M | ﹤0.01% |
27,145
+2,990
| +12% | +$1.23M |
|
|
PRXL
1277
DELISTED
Parexel International Corp
PRXL
| $11.6M | ﹤0.01% |
220,380
+12,700
| +6% | +$637K |
|
|
ADT
1278
DELISTED
ADT Corp
ADT
| $11.6M | ﹤0.01% |
331,231
-1,390,500
| -81% | -$44.6M |
|
|
MTCN
1279
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $11.5M | ﹤0.01% |
506,372
+11,469
| +2% | +$271K |
|
1280
Cincinnati Financial
CINF
$26.6B
| $11.4M | ﹤0.01% |
237,509
+12,900
| +6% | +$627K |
|
|
SP
1281
DELISTED
SP Plus Corporation
SP
| $11.4M | ﹤0.01% |
531,180
+167,660
| +46% | +$3.91M |
|
1282
Deckers Outdoor
DECK
$12.8B
| $11.3M | ﹤0.01% |
784,560
+78,000
| +11% | +$1.04M |
|
|
SEE
1283
DELISTED
Sealed Air
SEE
| $11.2M | ﹤0.01% |
328,564
-1,100
| -0.3% | -$36.4K |
|
|
ESL
1284
DELISTED
Esterline Technologies
ESL
| $11.2M | ﹤0.01% |
97,390
+6,600
| +7% | +$729K |
|
|
TGNA
1285
DELISTED
TEGNA Inc
TGNA
| $11.2M | ﹤0.01% |
681,431
+4,206
| +0.6% | +$61.6K |
|
|
GRMN
1286
Garmin
GRMN
$60.2B
| $11.1M | ﹤0.01% |
182,700
| – | – |
|
1287
Pultegroup
PHM
$24.7B
| $11M | ﹤0.01% |
547,822
+13,000
| +2% | +$250K |
|
|
KMG
1288
DELISTED
KMG Chemicals Inc
KMG
| $11M | ﹤0.01% |
612,900
+4,000
| +0.7% | +$65.3K |
|
|
ISH
1289
DELISTED
INTL SHIPHOLDING CORP
ISH
| $11M | ﹤0.01% |
479,300
+2,450
| +0.5% | +$61.9K |
|
1290
Evercore
EVR
$12B
| $11M | ﹤0.01% |
190,287
+182,287
| +2,279% | +$10M |
|
|
FST
1291
DELISTED
FOREST OIL CORPORATION
FST
| $11M | ﹤0.01% |
4,804,200
+4,769,300
| +13,666% | +$10.2M |
|
|
AKRX
1292
DELISTED
Akorn Inc
AKRX
| $10.9M | ﹤0.01% |
328,400
+22,300
| +7% | +$585K |
|
|
NWHM
1293
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $10.9M | ﹤0.01% |
772,246
+33,646
| +5% | +$446K |
|
1294
Innoviva
INVA
$1.51B
| $10.8M | ﹤0.01% |
363,346
-76,414
| -17% | -$1.83M |
|
|
STRZA
1295
DELISTED
Starz - Series A
STRZA
| $10.6M | ﹤0.01% |
355,850
+45,300
| +15% | +$1.38M |
|
|
ROSE
1296
DELISTED
ROSETTA RESOURCES INC
ROSE
| $10.6M | ﹤0.01% |
192,400
+17,200
| +10% | +$836K |
|
|
QEP
1297
DELISTED
QEP RESOURCES, INC.
QEP
| $10.5M | ﹤0.01% |
304,140
+34,700
| +13% | +$1.1M |
|
1298
Williams-Sonoma
WSM
$28.6B
| $10.5M | ﹤0.01% |
292,200
-13,400
| -4% | -$441K |
|
1299
Essent Group
ESNT
$6.24B
| $10.4M | ﹤0.01% |
519,890
-9,560
| -2% | -$194K |
|
|
TVTY
1300
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $10.4M | ﹤0.01% |
595,230
-7,660
| -1% | -$132K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.